Arterius Company
Arterius developing a novel next-generation polymer-based Bio-resorbable Coronary Scaffold (BRS), more commonly known as a ‘stent’.
Industry:
PharmTech
Headquarters:
Leeds, Leeds, United Kingdom
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Register and Claim Ownership